The Imperative for More Diverse Participants in Medical Research
The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you consent to the use of cookies. 

The Imperative for More Diverse Participants in Medical Research

January 31, 2023 | Report

Patient outcomes vary depending on the existence of clinical research focused on what works for diverse patients

Some communities are underrepresented in drug trials and underserved in health care access and education, and these inequities negatively affect society and business. Diversity in medical research improves patient outcomes, providing a pathway to advancing health equity. The effectiveness and affordability of drugs, medical treatments, and health practices contribute to the well-being of an increasingly diverse workforce. Healthy workers produce more and help contain the spiraling costs of health care and insurance. Leaders across all industries can contribute to solutions.

AUTHORS

David L.Gonzales

Senior Fellow, Human Capital
The Conference Board
Global Chief Diversity Officer (former)
Bristol-Myers Squibb

ReginaBrayboy

Senior Fellow and Healthcare Forum Leader, Human Capital
The Conference Board

AllanSchweyer

Principal Researcher, Human Capital
The Conference Board

MeenakshiJanardhanan

Research Associate, Marketing & Communications
The Conference Board


OTHER RELATED CONTENT

CONFERENCES & EVENTS

Diversity, Equity, and Inclusion

Diversity, Equity, and Inclusion

June 12 - 13, 2025 | (Brooklyn, NY)

COUNCILS

hubCircleImage